Vasopressor Update Critical Matters podcast

Content provided by Sound Physicians. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sound Physicians or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Critical Matters «
Vasopressor Update

6+ y ago 29:00

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on September 18, 2019 01:31 (4+ y ago). Last successful fetch was on July 01, 2019 13:06 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In our first episode, we discuss the potential role of Angiotensin II for treating shock and review the results of the ATHOS-3 clinical trial.

Our guest is Stephen W. Trzeciak, MD, MPH. Dr. Trzeciak is Interim Chair of Internal Medicine and Head of Critical Care Medicine at Cooper University Health Care. Dr. Trzeciak holds academic appointments as Professor of Medicine and Professor of Emergency Medicine at Cooper Medical School of Rowan University. He is also a prolific investigator and author, with recognized expertise in the treatment of shock, early interventions in critical illness, and the interface between the emergency department and the intensive care unit.

Additional Resources

Sound Critical Care webinar on vasopressors. Please review for a more comprehensive discussion on current evidence-based vasopressor use in clinical practice.
ATHOS-3 clinical trial. Randomized controlled trial evaluating the efficacy of Angiotensin II in raising blood pressure in vasodilatory shock.
FDA press release. After recording this podcast, the FDA announced the approval of Angiotensin II.

33 episodes

#Science #Medicine #Critical Care #Sound Physicians